Peptides DB
Research-centric peptide and protocol reference hub
Study 9 of 16Sermorelin literatureSynthetic and systems biotechnology2026

scYeast: a biological-knowledge-guided foundation model on yeast single-cell transcriptomics.

scYeast is a promising tool for advancing yeast single-cell biology by integrating biological priors into foundational models.

Read at Synthetic and systems biotechnologyAdd to compare

Where it sits

this study against the rest of the sermorelin corpus
9
Preclinical · this one
7
Observational
0
Open-label
0
Randomised
0
Reviews

Summary and findings

The study introduces scYeast, a foundational model for yeast single-cell transcriptomics that incorporates biological priors. It uses a novel architecture to enhance transcriptional regulatory information processing. scYeast shows strong performance in tasks like cell state classification and gene perturbation response prediction.

How much of this paper we could read: full text read (0.70). We had a clear abstract, so the summary below closely tracks the paper. What this means →
2026

Abstract

The authors’ words, as Synthetic and systems biotechnology supplied them

Though large-scale pre-trained models are vital for foundational cell modeling, most of them focus on human or mouse systems, with less emphasis on model organisms like yeast (<i>Saccharomyces cerevisiae</i>), and fail to use existing biological prior knowledge effectively. Here, we present scYeast, the first foundational cell model for yeast single-cell transcriptomics that effectively embeds biological priors. scYeast employs a novel asymmetric parallel architecture to infuse transcriptional regulatory information into the Transformer's attention mechanism, leveraging biological knowledge during training. Pre-trained on large-scale yeast single-cell transcriptomics data, scYeast demonstrates strong generalization and biological interpretability. It shows capability in zero-shot tasks, such as inferring regulatory relationships. After fine-tuning, scYeast performs well in diverse tasks, including cell state classification, growth doubling time prediction, and gene perturbation response prediction. Additionally, using transfer learning, scYeast can be adapted to other omics datasets, such as proteomics, thus broadening its utility. Overall, scYeast is a promising tool for yeast single-cell biology research and presents a new framework for integrating foundational models with biological priors, accelerating discovery in yeast synthetic and systems biology and providing a replicable framework for other organisms.

Background

The study addresses the need for foundational models in yeast single-cell transcriptomics, a less emphasized area compared to human or mouse systems. Existing models often neglect to incorporate biological prior knowledge effectively. This research is significant as it aims to enhance the utility of yeast as a model organism by integrating biological priors into computational models, potentially accelerating discoveries in synthetic and systems biology.

Methods

scYeast employs an asymmetric parallel architecture to integrate transcriptional regulatory information into the Transformer's attention mechanism. It is pre-trained on large-scale yeast single-cell transcriptomics data. The model is designed to perform zero-shot tasks and can be fine-tuned for specific tasks such as cell state classification and growth doubling time prediction. Additionally, it supports transfer learning to other omics datasets.

Results

scYeast shows strong generalization and biological interpretability in yeast single-cell biology. It performs well in zero-shot tasks like inferring regulatory relationships and excels in fine-tuned tasks such as cell state classification and growth doubling time prediction. The model's adaptability to other omics datasets, like proteomics, demonstrates its broad utility.

Interpretation

The introduction of scYeast represents a significant advancement in yeast single-cell transcriptomics by effectively embedding biological priors. While the model shows strong potential, the abstract does not provide specific quantitative results or comparisons to existing models. The study's implications for practice are promising, particularly in synthetic and systems biology, though the clinical relevance remains low due to the focus on yeast.

Key findings

  • scYeast demonstrates strong generalization and biological interpretability.
  • Performs well in zero-shot tasks such as inferring regulatory relationships.
  • After fine-tuning, excels in cell state classification and growth doubling time prediction.
  • Capable of transfer learning to other omics datasets like proteomics.

Limitations

  • Not reported in abstract.

Elsewhere in the Sermorelin corpus

BDiabetes-associated MYT1 and ST18 genes regulate human beta cell insulin secretion and survival via other diabetes risk genes.Diabetologia · 2026 · Enrichment of 2.05-fold relative to the random distribution of beta cell-expressed genes.HumanBGardnerella enrichment in the vaginal microbiome of women with gestational diabetes mellitus is associated with lower fetal birthweight percentiles.Diabetologia · 2026 · Gardnerella abundance was 9.7% in GDM vs 1.4% in controls, nominal p=0.011.HumanCReconstituting a two-step pathway for &lt;i&gt;N&lt;/i&gt;,&lt;i&gt;N&lt;/i&gt;-dimethyltryptamine (DMT) biosynthesis in bacteria.Metabolic engineering communications · 2026 · 103 mg/L DMT after 48 hours in complex medium.In vitroCImpact of secretome containing extracellular vesicles from human induced pluripotent stem cell-derived cardiomyocytes.Regenerative therapy · 2026 · Not reported in abstract.In vitroCMetabolic engineering of &lt;i&gt;Escherichia coli&lt;/i&gt; based on adaptive evolution and omics technology for highly efficient l-valine production under oxygen-limited conditions.Synthetic and systems biotechnology · 2026 · l-valine titer of 93.7 g/L within 28 h in a 5-L bioreactor.In vitroCIdentification of integration site library for the development of plasmid-free microbial cell factory in &lt;i&gt;Bacillus subtilis&lt;/i&gt;.Synthetic and systems biotechnology · 2026 · The highest expression site spxA was 1.89 times as high as amyE.In vitro